$CXW

GARFINKLE DAVID sold $1.7M of CXW

GARFINKLE DAVID (EVP & Chief Financial Officer) sold 50,000 shares of CoreCivic, Inc. (CXW) at $33.96 ($1.70M total) on 2026-08-21.

Original reporting
SEC EDGAR · GARFINKLE DAVID
Published Aug 21, 2026, 9:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CXW
Bearish
medium confidence
Mentioned
$CXW
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CXWBearishLow
01

Why it matters

The sale reduces insider ownership, potentially affecting investor perception of management confidence.

02

Market read

A senior insider's $1.7M share sale may prompt short‑term price pressure.

03

What to watch

No 10b5‑1 plan; sale may be opportunistic given share price level.

Relevance 6/10Novelty 5/10Timing: today

Background

Form 4 filings disclose insider transactions; CFO sales are closely watched by investors.

Company-level read

Ticker impact

$CXWBearishMedium confidence
Context

CFO David Garfinkle sold 50,000 CoreCivic shares for $1.7M, reducing his stake to 293,353 shares.

Expected impact

Possible short-term downside as market digests insider sell.

Evidence & confidence

CFO is a senior insider; a $1.7M open‑market sale is material for a mid‑cap prison‑operator, likely to influence sentiment.

Market effects

May raise concerns for the private‑prison sector and related REITs.

Limited to US markets where CoreCivic trades.

Low global relevance.

Counterpoint

Insider sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • CoreCivic, Inc.

    US prison‑operator listed as CXW.

  • David Garfinkle

    Chief Financial Officer of CoreCivic.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CXWHighAI 9/10

CoreCivic Soars as Massive ICE Funding Sparks Rally

CoreCivic (CXW) shares rose due to a $75 billion federal funding package for ICE and border security through 2029. Investors expect higher detention contracts and revenue. The company's real estate monetization and long-term contracts provide stability, but risks include policy changes and weak cash flow conversion.

$CXWMed

CoreCivic Inc stock hits 52-week high at $34.88

CoreCivic Inc. (CXW) stock reached a 52-week high of $34.88, with a 70.29% increase over the past year. The company reported Q2 2026 earnings of $0.38 per share, surpassing estimates, and announced a $500M share repurchase agreement. According to InvestingPro, the stock appears overvalued but has a low PEG ratio of 0.84.

$CXWHigh

Financial Outperformance and Demand Tailwinds Lead to Bullish Narrative Around CoreCivic (CXW)

Noble Capital reiterated its Outperform rating on CoreCivic (CXW), raising its target price to $42 from $35, citing strong Q2 results. The company reported $684.9M revenue, up 27.3% YoY, and adjusted EBITDA of $109.4M, up 5.9% YoY. CoreCivic also secured a new ICE contract and plans share buybacks and debt reduction. Risks include policy changes and revenue concentration.

$GEOHighAI 8/10

GEO Group And CoreCivic Stocks Are Getting Beaten Up Today – Why Such A Selloff?

GEO Group (GEO) and CoreCivic (CXW) shares fell after a Bloomberg report indicated ICE plans to reduce its network of private detention facilities to 34 government-owned locations. ICE contracts account for nearly half of GEO's projected 2026 revenue ($2.9B-$3.1B) and 40% of CoreCivic's Q4 revenue. Despite the reduction, private companies may still provide services like medical care and security.

$CXWMedAI 8/10

CoreCivic (CXW) Lifted Its 2026 Guidance, Is The Stock Still Undervalued?

CoreCivic (CXW) raised its 2026 guidance, expecting net income of $1.492B-$1.511B and EPS of $15.62-$15.82. The stock has seen significant gains, with a 3-year return of 209.08%, but recent momentum has eased. Analysts debate its valuation, with some seeing it as 19.2% undervalued at $31.99 per share, while others point to a high P/E ratio of 24.7x.